Skip to main content

Table 1 Patient attributes at beginning of esmolol infusion

From: Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study

Variable

Esmolol-treated patients (n = 7)

Age (years)

46 (± 19)

Female sex

5 (71%)

Cause of sepsis n (%)

 Pneumonia

2 (29%)

 Skin/soft tissue

3 (43%)

 Urinary source

1 (14%)

 Abdominal

1 (14%)

Duration of vasopressor therapy (hours)a

15.1 (± 9)

Norepinephrine infusion rate (μg/kg/min)

0.20 (± 0.09)

Receiving vasopressin n (%)

2 (29%)

Heart rate (/min)

109 (± 15)

Mean arterial pressure (mmHg)

71 (± 7)

Lactate (mmol/L)b

4.8 (± 3.3)

Intravenous crystalloid prior to enrollment (L)

3.5 (3.4–9.0)

Admission APACHE II score (points)

28 (± 8)

Admission SOFA score (points)

11 (± 2)

  1. Values are reported as central tendency and variation, expressed as mean (± standard deviation) or median (inter-quartile range), as appropriate
  2. aAt time of initiating esmolol infusion
  3. bPeak lactate on day of enrollment
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784